Helping Clients Derive Valuable Insights from Their Data Since 1996
What’s New
Kayris™ Is Here
We’re proud to announce the launch of Kayris™, a free app that gives you a clear, clinically grounded picture of your cardiovascular and metabolic risk — calculated entirely on your device, using the same equations used in clinical practice (2024 AHA PREVENT™, ACC/AHA Pooled Cohort Equations, and an ADA-based diabetes risk estimator). Every result comes with the specific, actionable steps most likely to change your trajectory, not just a number. Available now for iOS and Android, with a free browser-based calculator too — learn more at kayris.health.
Find out more at Kayris.Health or by clicking Kayris™ on the menu bar.
Chimeric mRNA could provide new insight into difficult-to-treat diseases
- Researchers have discovered that mammalian genes can combine to make chimeric mRNAs, which carry the instructions to produce previously unknown, functional proteins.
- The first chimeric mRNA they investigated, in mice, has an important role in modulating inflammatory responses.
- Findings expand understanding of biology, genome and add potentially thousands of new targets for drug discovery.
Read the Harvard Medical School article here.
Read the article in Nature
Underwriting Margin Model
The latest (2024 update) Medicaid Managed Care Underwriting Margin Model that Mardo Atoyan of HealthCare Analytics coauthored with Tom Donlon of Legacy 3 Consulting, and Grant Porter of Faulkner Consulting Group, is now available for download here at the SOA website.